Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **suprachoroidal outflow pathway** is an anatomical route in the eye responsible for a proportion of aqueous humor drainage from the anterior chamber. After passing through the trabecular meshwork and uveoscleral structures, aqueous humor percolates through connective tissues of the ciliary body and into the **suprachoroidal space** (between the sclera and choroid), where it is then absorbed by scleral and choroidal blood vessels. This passive route is independent of active molecular transport and plays a greater role in intraocular pressure regulation in younger individuals but declines with age. Surgical implants and pharmacological agents aim to augment this pathway as a treatment for glaucoma by increasing fluid drainage through this space.
Increase permeability of connective tissues in the uveoscleral pathway to enhance aqueous humor outflow, reducing intraocular pressure
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suprachoroidal outflow pathway.